Moses & Singer Announces Newly-Elevated Lawyers

January 30, 2012

Moses & Singer is pleased to announce that Jill E. Anderson and Samuel J. Servello have become partners in the firm’s Healthcare Group, and Amyt M. Eckstein is now of counsel to the Intellectual Property Group. “We are proud to announce the elevation of Jill, Sam and Amyt,” remarked Alan Kolod, Firm Chairman. “They exemplify the firm’s commitment to outstanding client service and exceptional legal expertise.”

Jill AndersonJill E. Anderson

Jill is a partner in the Healthcare and Privacy Groups at Moses & Singer. She has extensive experience in healthcare transactions and counsels biotechnology and pharmaceutical companies, contract research organizations, academic medical centers, teaching hospitals and research foundations on regulatory and compliance issues related to research and the privacy and security of data. Jill has significant experience drafting and negotiating transactional agreements and identifying regulatory and compliance risks related to research. She counsels clients in matters involving clinical trials, pre-clinical and translational research including therapeutics, diagnostics, genomics, proteomics, personalized medicine (pharmacogenomics), biorepositories, Medicare reimbursement, research misconduct, fraud and abuse issues, anti-kickback laws, and clinical trial disclosure and registration requirements. Jill also provides strategic advice to a variety of healthcare clients on complex privacy and security issues related to electronic data management. She advises clients on how to preserve, protect and recover electronic data as well as how to address potential and actual data security breaches and vulnerabilities.

Samuel ServelloSamuel J. Servello

Sam is a partner in the firm’s Healthcare and Privacy Groups. His practice focuses on healthcare law and taxation of not-for-profit entities. He advises hospital systems, long-term care facilities, health plans, pharmaceutical companies and banks on transactional matters, privacy issues and regulatory compliance. Sam also provides guidance on fraud and abuse issues and medical banking concerns. He has extensive experience negotiating research grants and clinical trial agreements; advising on the tax implications of clinical trials activities and issues relating to exemption from taxation; and assisting tax-exempt organizations obtain recognition of tax-exempt status, maintaining tax-exempt status and navigating the complexities of unrelated business taxable income, including income from conducting clinical research.

Amyt M. Eckstein

Amyt is counsel to the firm’s Intellectual Property, Internet/Technology, Sports & Entertainment, Advertising and Privacy Groups. He represents domestic and international companies from a variety of sectors, including financial services, technology, media, and healthcare, in IT related transactional matters. Clients seek his counsel in matters involving electronic commerce, intellectual property, privacy, outsourcing, open source, hardware and software development, as well as issues concerning emerging laws and regulations affecting the technology aspects of regulated and unregulated industries. He advises on privacy, security and technology issues relating to financial services and healthcare services (HIPAA and HITECH compliance) transactions and compliance with respect to protected personal, financial, and health information. Amyt represents companies offering products and services over the Internet and counsels clients on web site disclosures, contractual arrangements, advertising, privacy programs and policies. Amyt provides guidance on content and technology development and distribution and online exploitation and helps assess and mitigate the risks associated with e-commerce and Internet presence.

For more information, please visit us at